| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |